PolyPid Hosts Virtual Investor Day to Outline Long — Term Growth Strategy
PolyPid will host a virtual Investor Day on October 28, 2026, at 11:30 a.m. ET. Management will outline its “PolyPid 2030” long-term growth and pipeline strategy. An update will cover D-PLEX₁₀₀ for colorectal surgical infection prevention, under FDA priority review with a November 28, 2026, decision target. Management